aztreonam has been researched along with Pregnancy in 43 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty-two patients who had postpartum endometritis were treated with clindamycin in combination with either aztreonam or the aminoglycoside gentamicin." | 9.06 | Comparison trial of clindamycin with aztreonam or gentamicin in the treatment of postpartum endometritis. ( Bollinger, M; Greenberg, RN; Ojile, JM; Reilly, PM; Weinandt, WJ; Wilson, KM, 1987) |
| "5 mg/kg intravenously every eight hours), each with clindamycin (600 mg intravenously every six hours), was performed in 119 patients with endometritis after cesarean section." | 9.05 | Aztreonam versus gentamicin, each with clindamycin, in the treatment of endometritis. ( Blanco, JD; Gibbs, RS; Lipscomb, KA; St Clair, PJ, 1985) |
| "The transplacental passage of single intravenous doses of aztreonam (AZT), 1 g or 2 g, was examined in 7 sheep and 14 women in late pregnancy, respectively and the obtained data were analyzed by a two-compartment model." | 7.67 | [Pharmacokinetic studies on aztreonam in late pregnancy in sheep and humans]. ( Akahane, M; Fujimoto, S; Hagisawa, M; Hattori, T; Ichinoe, K; Ishiguro, N; Nakajima, T; Sato, H; Sugawara, T; Takeda, K, 1986) |
| "The materno-fetal transfer of aztreonam by a single intravenous dose of 1 g was examined in 7 volunteer women undergoing induced abortion in early pregnancy and the following results were obtained." | 7.67 | [Studies of aztreonam transfer into the fetus and amniotic fluid in early pregnancy]. ( Akahane, M; Fujimoto, S; Hanatani, K; Hashimoto, M; Ichinoe, K; Sakuragi, N; Sato, H, 1986) |
| "Aztreonam (AZT) was evaluated for its clinical efficacy in 6 patients with pelvic peritonitis." | 7.67 | [Clinical efficacy of aztreonam in pelvic peritonitis]. ( Abe, Y; Funaki, K; Nakakuki, M; Okamura, K; Yamada, K, 1985) |
| "Sixty-two patients who had postpartum endometritis were treated with clindamycin in combination with either aztreonam or the aminoglycoside gentamicin." | 5.06 | Comparison trial of clindamycin with aztreonam or gentamicin in the treatment of postpartum endometritis. ( Bollinger, M; Greenberg, RN; Ojile, JM; Reilly, PM; Weinandt, WJ; Wilson, KM, 1987) |
| "Multicenter trials were conducted to determine the safety and efficacy of aztreonam in the treatment of patients with gram-negative bacterial infections." | 5.05 | Aztreonam: worldwide overview of the treatment of patients with gram-negative infections. ( Bendush, CB; Henry, SA, 1985) |
| "5 mg/kg intravenously every eight hours), each with clindamycin (600 mg intravenously every six hours), was performed in 119 patients with endometritis after cesarean section." | 5.05 | Aztreonam versus gentamicin, each with clindamycin, in the treatment of endometritis. ( Blanco, JD; Gibbs, RS; Lipscomb, KA; St Clair, PJ, 1985) |
| "Endomyometritis is the most common complication associated with cesarean delivery." | 3.76 | Pathophysiology and management of postcesarean endomyometritis. ( Duff, P, 1986) |
| "Aztreonam (AZT) was evaluated for its clinical efficacy in 6 patients with pelvic peritonitis." | 3.67 | [Clinical efficacy of aztreonam in pelvic peritonitis]. ( Abe, Y; Funaki, K; Nakakuki, M; Okamura, K; Yamada, K, 1985) |
| "Aztreonam (AZT) was evaluated for its clinical efficacy in a total of 10 cases, namely 3 cases of endometritis, 6 cases of intrapelvic infections, 1 case of puerperal pyelonephritis." | 3.67 | [Clinical evaluation of aztreonam in the field of obstetrics and gynecology]. ( Ijuin, H, 1985) |
| " Pharmacokinetic study (1) Upon one-shot intravenous injection of AZT 1 g before delivery, maternal serum concentration of AZT was 89." | 2.67 | [Pharmacokinetics and clinical evaluations on aztreonam in perinatal infections in obstetrics and gynecology. A study of aztreonam in the perinatal co-research group]. ( Haga, H; Hirayama, H; Inoue, R; Matsuda, S; Mizoguchi, H; Oh, K; Sengoku, K; Shimizu, T; Tori-i, Y; Yamazaki, T, 1990) |
| "Aztreonam is a synthetic monobactam antibiotic that has excellent activity against aerobic gram-negative bacilli." | 2.38 | Aztreonam. ( Clark, P, 1992) |
| "The aim of this study was to build and verify a preliminary physiologically based pharmacokinetic (PBPK) model of Chinese pregnant women." | 1.56 | Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women. ( Li, X; Liu, D; Liu, X; Song, L; Xu, Y; Yu, Z; Zhou, T, 2020) |
| "Aztreonam (AZT) was administered to 73 cases and its usefulness and safety were evaluated upon review of the transfer of the drug into maternal blood, umbilical cord blood and amniotic fluid." | 1.28 | [Pharmacokinetic study of aztreonam transfer from mother to fetus]. ( Hayashi, S; Imakawa, N; Obata, I; Yamato, T, 1990) |
| " Efficacy rate of AZT in the clinical application to 12 cases of perinatal infections via 2-4 g/day drip infusion (total dosage 8-24 g) was 91." | 1.28 | [Clinical studies on aztreonam in perinatal use]. ( Chimura, T; Funayama, T; Matsuo, M; Morisaki, N, 1990) |
| "[14C]aztreonam (150 mg/kg) was also administered subcutaneously to lactating rats." | 1.27 | Distribution of aztreonam into fetuses and milk of rats. ( Ita, CE; Keim, GR; Migdalof, BH; Shaw, JM; Singhvi, SM, 1984) |
| "Aztreonam (AZT) was studied for the transfer into the pelvic dead space exudate in 5 patients who received radical hysterectomy due to uterocervical cancer, and for the clinical efficacy in the treatment of 5 cases of obstetrical and gynecological infections." | 1.27 | [Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology]. ( Hayasaki, M; Ito, K; Matsunami, K; Noda, K, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (58.14) | 18.7374 |
| 1990's | 13 (30.23) | 18.2507 |
| 2000's | 1 (2.33) | 29.6817 |
| 2010's | 1 (2.33) | 24.3611 |
| 2020's | 3 (6.98) | 2.80 |
| Authors | Studies |
|---|---|
| Bitew, A | 1 |
| Bati, S | 1 |
| Bigaud, M | 1 |
| Rudolph, B | 1 |
| Briard, E | 1 |
| Beerli, C | 1 |
| Hofmann, A | 1 |
| Hermes, E | 1 |
| Muellershausen, F | 1 |
| Schubart, A | 1 |
| Gardin, A | 1 |
| Hed, S | 1 |
| Matlov Kormas, R | 1 |
| Shashar, S | 1 |
| Malyugin, BE | 1 |
| Boyko, M | 1 |
| Knyazer, B | 1 |
| Nguyen Truong, G | 1 |
| Hoang Vinh, L | 1 |
| Huynh Thu, S | 1 |
| Nguyen Thi Hong, P | 1 |
| Nguyen Quang, B | 1 |
| White, MG | 1 |
| Szczepaniak Sloane, R | 1 |
| Witt, RG | 1 |
| Reuben, A | 1 |
| Gaudreau, PO | 1 |
| Andrews, MC | 1 |
| Feng, N | 1 |
| Johnson, S | 1 |
| Class, CA | 1 |
| Bristow, C | 1 |
| Wani, K | 1 |
| Hudgens, C | 1 |
| Nezi, L | 1 |
| Manzo, T | 1 |
| De Macedo, MP | 1 |
| Hu, J | 2 |
| Davis, R | 1 |
| Jiang, H | 1 |
| Prieto, P | 1 |
| Burton, E | 1 |
| Hwu, P | 1 |
| Tawbi, H | 1 |
| Gershenwald, J | 1 |
| Lazar, AJ | 1 |
| Tetzlaff, MT | 1 |
| Overwijk, W | 1 |
| Woodman, SE | 1 |
| Cooper, ZA | 1 |
| Marszalek, JR | 1 |
| Davies, MA | 1 |
| Heffernan, TP | 1 |
| Wargo, JA | 1 |
| Jha, V | 1 |
| Purohit, H | 1 |
| Dafale, NA | 1 |
| Moursi, AS | 1 |
| El-Fishawy, N | 1 |
| Djahel, S | 1 |
| Shouman, MA | 1 |
| Li, C | 1 |
| Yu, L | 1 |
| Jiang, Y | 1 |
| Cui, Y | 1 |
| Liu, Y | 1 |
| Shi, K | 1 |
| Hou, H | 1 |
| Liu, M | 1 |
| Zhang, W | 2 |
| Zhang, J | 1 |
| Zhang, C | 1 |
| Chen, M | 3 |
| Lu, L | 1 |
| Zheng, P | 1 |
| Wu, Z | 1 |
| Chen, X | 1 |
| Parisi, A | 1 |
| Cortellini, A | 1 |
| Venditti, O | 1 |
| Filippi, R | 1 |
| Salvatore, L | 1 |
| Tortora, G | 1 |
| Ghidini, M | 1 |
| Nigro, O | 1 |
| Gelsomino, F | 1 |
| Zurlo, IV | 1 |
| Fulgenzi, C | 1 |
| Lombardi, P | 1 |
| Roselló Keränen, S | 1 |
| Depetris, I | 1 |
| Giampieri, R | 1 |
| Morelli, C | 1 |
| Di Marino, P | 1 |
| Di Pietro, FR | 1 |
| Zanaletti, N | 1 |
| Vitale, P | 1 |
| Garajova, I | 1 |
| Spinelli, GP | 1 |
| Zoratto, F | 1 |
| Roberto, M | 1 |
| Petrillo, A | 1 |
| Aimar, G | 1 |
| Patruno, L | 1 |
| D'Orazio, C | 1 |
| Ficorella, C | 1 |
| Ferri, C | 1 |
| Porzio, G | 1 |
| Carinato, H | 1 |
| Burgy, M | 1 |
| Ferry, R | 1 |
| Fischbach, C | 1 |
| Kalish, M | 1 |
| Guihard, S | 1 |
| Brahimi, Y | 1 |
| Flesch, H | 1 |
| Bronner, G | 1 |
| Schultz, P | 1 |
| Frasie, V | 1 |
| Thiéry, A | 1 |
| Demarchi, M | 1 |
| Petit, T | 1 |
| Jung, AC | 1 |
| Wagner, P | 1 |
| Coliat, P | 1 |
| Borel, C | 1 |
| Yang, Y | 2 |
| Tang, Z | 1 |
| Ji, J | 1 |
| Yang, C | 1 |
| Han, B | 1 |
| Wang, Y | 3 |
| Guo, H | 1 |
| Gao, X | 1 |
| Wang, J | 1 |
| Cao, J | 1 |
| Zhang, B | 1 |
| Topatana, W | 1 |
| Li, S | 2 |
| Juengpanich, S | 1 |
| Lu, Z | 1 |
| Cai, X | 1 |
| Guan, W | 1 |
| Yang, S | 1 |
| Zhao, Y | 1 |
| Cheng, W | 1 |
| Song, X | 1 |
| Yao, Y | 1 |
| Xie, Y | 1 |
| Du, W | 1 |
| Li, J | 1 |
| Chen, XF | 1 |
| Fan, X | 1 |
| Hou, X | 1 |
| Liu, XY | 1 |
| Huang, JJ | 1 |
| Kang, W | 2 |
| Zhang, G | 1 |
| Zhang, H | 2 |
| Yang, WH | 1 |
| Li, YX | 1 |
| Wang, JW | 1 |
| Guo, DW | 1 |
| Sun, ZY | 1 |
| Chen, ZJ | 1 |
| Zou, LG | 1 |
| Du, XF | 1 |
| Pan, YH | 1 |
| Li, B | 1 |
| He, H | 1 |
| Xu, YC | 1 |
| Shi, D | 1 |
| Anwar, TM | 1 |
| Pan, H | 1 |
| Chai, W | 1 |
| Xu, S | 1 |
| Yue, M | 1 |
| Wang, W | 1 |
| Huang, S | 1 |
| Zou, C | 1 |
| Ding, Y | 1 |
| Wang, H | 2 |
| Pu, S | 1 |
| Liao, Y | 1 |
| Du, H | 1 |
| Wang, D | 1 |
| Chen, L | 1 |
| Niu, S | 1 |
| Harrison, MA | 1 |
| Kaur, H | 1 |
| Wren, BW | 1 |
| Dawson, LF | 1 |
| Yu, Y | 1 |
| Hu, B | 1 |
| Fan, H | 1 |
| Lian, S | 1 |
| Li, H | 1 |
| Yan, X | 1 |
| Wang, S | 1 |
| Bai, X | 1 |
| Mao, F | 1 |
| Chen, Y | 1 |
| Zhang, Q | 1 |
| Ding, X | 1 |
| Ni, B | 1 |
| Xu, X | 1 |
| Jin, X | 1 |
| Dai, Y | 1 |
| Fachler, T | 1 |
| Shteyer, E | 1 |
| Orlanski Meyer, E | 1 |
| Shemasna, I | 1 |
| Lev Tzion, R | 1 |
| Rachman, Y | 1 |
| Bergwerk, A | 1 |
| Turner, D | 1 |
| Ledder, O | 1 |
| Marianeschi, SM | 1 |
| Uricchio, N | 1 |
| Cerri, GB | 1 |
| Ghiselli, S | 1 |
| Carro, C | 1 |
| Albano, G | 1 |
| Viola, N | 1 |
| Li, Y | 2 |
| Zhang, Y | 1 |
| Liu, C | 1 |
| Li, X | 2 |
| Zhou, Q | 1 |
| Sun, C | 2 |
| Zhang, L | 2 |
| Singh, D | 1 |
| Raghunathan, V | 1 |
| Dhaliwal, M | 1 |
| Rastogi, N | 1 |
| Chadha, R | 1 |
| Yadav, SP | 1 |
| Shah, M | 1 |
| Han, JH | 1 |
| Park, H | 1 |
| Kim, HW | 1 |
| Park, KB | 1 |
| Zhou, J | 1 |
| Huang, H | 1 |
| Zhu, Q | 1 |
| Wen, F | 1 |
| Dong, Y | 1 |
| Hu, Y | 1 |
| Pan, P | 1 |
| Hong, C | 1 |
| Fang, L | 1 |
| Gu, S | 1 |
| Lai, J | 1 |
| Zhu, X | 1 |
| Ji, T | 1 |
| Feng, J | 1 |
| Zhao, L | 1 |
| Li, Z | 2 |
| Dong, L | 1 |
| Hou, G | 1 |
| Zhu, Y | 1 |
| He, C | 1 |
| Geng, H | 1 |
| Pang, D | 1 |
| Song, L | 1 |
| Yu, Z | 1 |
| Xu, Y | 1 |
| Liu, X | 1 |
| Liu, D | 1 |
| Zhou, T | 1 |
| Yamanaka, Y | 1 |
| Shimabukuro, A | 1 |
| De Maria, C | 1 |
| Lebel, D | 1 |
| Desroches, A | 1 |
| Gauvin, F | 1 |
| Singhvi, SM | 1 |
| Ita, CE | 1 |
| Shaw, JM | 1 |
| Keim, GR | 1 |
| Migdalof, BH | 2 |
| Itakura, A | 1 |
| Kurauchi, O | 1 |
| Mizutani, S | 1 |
| Tomoda, Y | 1 |
| Matsuzawa, K | 1 |
| Clark, P | 1 |
| Chimura, T | 3 |
| Satou, S | 1 |
| Funayama, T | 2 |
| Oono, T | 1 |
| Sakai, Y | 1 |
| Morisaki, N | 3 |
| Kanasugi, H | 1 |
| Takahashi, H | 1 |
| Saitou, N | 1 |
| Miyata, R | 1 |
| Cho, N | 2 |
| Fukunaga, K | 2 |
| Kunii, K | 2 |
| Kobayashi, I | 1 |
| Matsuda, S | 2 |
| Oh, K | 2 |
| Hirayama, H | 2 |
| Shimizu, T | 2 |
| Sengoku, K | 2 |
| Haga, H | 2 |
| Inoue, R | 2 |
| Yamazaki, T | 2 |
| Mizoguchi, H | 2 |
| Tori-i, Y | 1 |
| Obata, I | 1 |
| Yamato, T | 1 |
| Hayashi, S | 2 |
| Imakawa, N | 1 |
| Torii, Y | 1 |
| Sagawa, T | 1 |
| Saitou, S | 1 |
| Makinoda, S | 2 |
| Negishi, H | 1 |
| Ohkohchi, T | 1 |
| Hanatani, K | 2 |
| Satoh, H | 1 |
| Tanaka, T | 2 |
| Fujimoto, S | 4 |
| Matsuo, M | 1 |
| Ito, K | 2 |
| Hirose, R | 1 |
| Tamaya, T | 1 |
| Yamada, Y | 1 |
| Izumi, K | 1 |
| Yamamoto, T | 1 |
| Yasuda, J | 1 |
| Okada, H | 1 |
| Iwasaku, K | 1 |
| Greenberg, RN | 1 |
| Reilly, PM | 1 |
| Weinandt, WJ | 1 |
| Wilson, KM | 1 |
| Bollinger, M | 1 |
| Ojile, JM | 1 |
| Duff, P | 1 |
| Berthelot, G | 1 |
| Bergogne-Bérézin, E | 1 |
| Vernant, D | 1 |
| Ravina, JH | 1 |
| Akahane, M | 2 |
| Hagisawa, M | 1 |
| Nakajima, T | 1 |
| Hattori, T | 1 |
| Sato, H | 2 |
| Sugawara, T | 1 |
| Takeda, K | 1 |
| Ichinoe, K | 2 |
| Ishiguro, N | 1 |
| Sakuragi, N | 1 |
| Hashimoto, M | 1 |
| Seki, H | 1 |
| Maki, M | 1 |
| Inoue, K | 1 |
| Okamura, K | 1 |
| Nakakuki, M | 1 |
| Yamada, K | 1 |
| Abe, Y | 1 |
| Funaki, K | 1 |
| Kamiishi, H | 1 |
| Yanagihashi, T | 1 |
| Matsuzaki, Y | 1 |
| Uemura, T | 1 |
| Minaguchi, H | 1 |
| Tateno, M | 1 |
| Maruyama, C | 1 |
| Matsunami, K | 1 |
| Hayasaki, M | 1 |
| Noda, K | 2 |
| Ninomiya, K | 1 |
| Ohbayashi, F | 1 |
| Hasegawa, Y | 1 |
| Ushioda, E | 1 |
| Iioka, H | 1 |
| Shimamoto, I | 1 |
| Ichijo, M | 1 |
| Yamamoto, K | 2 |
| Shimizu, S | 1 |
| Yamamoto, A | 1 |
| Naka, K | 1 |
| Tatsuta, I | 1 |
| Ishikawa, O | 1 |
| Ohshika, Y | 1 |
| Umesaki, N | 1 |
| Sugawa, T | 1 |
| Horii, T | 1 |
| Ikeda, M | 1 |
| Shiota, M | 1 |
| Watanabe, Y | 1 |
| Hirabayashi, K | 1 |
| Okada, E | 1 |
| Yamada, E | 1 |
| Ueda, T | 1 |
| Mori, A | 1 |
| Haraguchi, H | 1 |
| Nagata, Y | 1 |
| Ijuin, H | 1 |
| Takamura, S | 1 |
| Ichinohe, K | 1 |
| Henry, SA | 1 |
| Bendush, CB | 1 |
| Gibbs, RS | 1 |
| Blanco, JD | 1 |
| Lipscomb, KA | 1 |
| St Clair, PJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment Utility of Postpartum Antibiotics in Chorioamnionitis[NCT01585129] | Phase 4 | 80 participants (Actual) | Interventional | 2010-09-30 | Terminated (stopped due to Futility in patient enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
This is the duration of hospital stay (in days) after their cesarean delivery. (NCT01585129)
Timeframe: Up to 7 Days
| Intervention | days (Mean) |
|---|---|
| Postpartum Antibiotics | 4 |
| No Postpartum Antibiotics | 4 |
Endometritis is defined as uterine infection and is diagnosed by maternal temp > 38.0C on two occasions over a 4 hour period or any temp > 39.0C after delivery > 12 hours after delivery. Endometritis will be managed per currently accepted endometritis protocol - (Amp 2 gQ6, Gentamicin 5 mg/kg q24, Clindamycin 900 mg q8). (NCT01585129)
Timeframe: 7 days post-partum
| Intervention | Participants (Count of Participants) |
|---|---|
| Postpartum Antibiotics | 4 |
| No Postpartum Antibiotics | 3 |
Infection related complications will include common complications attributed to infections there are not the primary outcome (endometritis). This will include infections of the wound and pelvic abscesses. (NCT01585129)
Timeframe: 7 days post-partum
| Intervention | Participants (Count of Participants) |
|---|---|
| Postpartum Antibiotics | 7 |
| No Postpartum Antibiotics | 2 |
2 reviews available for aztreonam and Pregnancy
| Article | Year |
|---|---|
Aztreonam.
Topics: Aztreonam; Bacterial Infections; Costs and Cost Analysis; Female; Genital Diseases, Female; Humans; | 1992 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Cli | 1986 |
6 trials available for aztreonam and Pregnancy
| Article | Year |
|---|---|
[Clinical effect of the combined use of aztreonam, amikacin and clindamycin in infectious disease in obstetrics and gynecology].
Topics: Adult; Aged; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Fema | 1991 |
[Pharmacokinetics and clinical evaluations on aztreonam in perinatal infections in obstetrics and gynecology. A study of aztreonam in the perinatal co-research group].
Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Clinical Trials as Topic; Female; Fetal Bloo | 1990 |
Comparison trial of clindamycin with aztreonam or gentamicin in the treatment of postpartum endometritis.
Topics: Adolescent; Adult; Aztreonam; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endo | 1987 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Cli | 1986 |
Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; Clini | 1985 |
Aztreonam versus gentamicin, each with clindamycin, in the treatment of endometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Cesarean Section; Clindamycin; Clinical Trials as Topic; Dr | 1985 |
36 other studies available for aztreonam and Pregnancy
| Article | Year |
|---|---|
Topics: Animals; Anti-Bacterial Agents; Antibodies, Protozoan; Antifungal Agents; Auranofin; Azabicyclo Comp | 2021 |
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Do | 2022 |
Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women.
Topics: Adult; Asian People; Aztreonam; Biological Transport; Ceftazidime; Ceftriaxone; Cefuroxime; Female; | 2020 |
Septic abortion presenting as a right lower trapezius abscess secondary to Bacteroides fragilis bacteraemia.
Topics: Abortion, Septic; Abscess; Adult; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacteremia; Bacteria | 2017 |
Simple intravenous antimicrobial desensitization method for pediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Child; Desensitization, Immunologic; Drug | 2002 |
Distribution of aztreonam into fetuses and milk of rats.
Topics: Amniotic Fluid; Animals; Anti-Bacterial Agents; Autoradiography; Aztreonam; Female; Fetus; Male; Mat | 1984 |
[The levels of aztreonam in the cord bloods and tissues after administration to pregnant women].
Topics: Aztreonam; Culture Techniques; Female; Fetal Blood; Humans; Infusions, Intravenous; Maternal-Fetal E | 1995 |
New diarrhea treatment coming?
Topics: Administration, Oral; Adult; Aztreonam; Bacterial Infections; Child; Diarrhea; Female; Humans; Pregn | 1992 |
[Studies on aztreonam in the perinatal period].
Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; | 1990 |
[Pharmacokinetic study of aztreonam transfer from mother to fetus].
Topics: Amniotic Fluid; Aztreonam; Female; Humans; Maternal-Fetal Exchange; Pregnancy; Umbilical Cord | 1990 |
[Pharmacokinetic and clinical studies on aztreonam in perinatal period].
Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Chorioamnionitis; Female; Fetal Blood; Genit | 1990 |
[Basic and clinical studies on aztreonam in obstetric and gynecologic infections during the perinatal period].
Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Female; Fetal Blood; Gram-Negative Bacteria; | 1990 |
[Clinical studies on aztreonam in perinatal use].
Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Humans; Infusions, Intravenous; Pre | 1990 |
[Transplacental transfer and clinical application of aztreonam].
Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Female; Fetal Blood; Humans; Infusions, Intr | 1990 |
[Pharmacokinetic and clinical studies on aztreonam in the perinatal period].
Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Female; Fetal Blood; Humans; Infusions, Intr | 1990 |
[Pharmacokinetic and clinical studies on aztreonam in the perinatal period in obstetrics and gynecology].
Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Fetal Blood; Humans | 1990 |
Aztreonam: disposition and pharmacokinetics in rats, dogs, and monkeys.
Topics: Animals; Aztreonam; Dogs; Female; Kinetics; Macaca fascicularis; Male; Pregnancy; Rats; Species Spec | 1986 |
[Diffusion of aztreonam in the tissues and biological fluids of the female genital tract].
Topics: Aztreonam; Diffusion; Endometrium; Fallopian Tubes; Female; Fetal Blood; Genitalia, Female; Humans; | 1986 |
[Pharmacokinetic studies on aztreonam in late pregnancy in sheep and humans].
Topics: Amniotic Fluid; Animals; Aztreonam; Female; Fetal Blood; Half-Life; Humans; Kinetics; Maternal-Fetal | 1986 |
[Studies of aztreonam transfer into the fetus and amniotic fluid in early pregnancy].
Topics: Adult; Amniotic Fluid; Aztreonam; Female; Fetus; Humans; Kinetics; Maternal-Fetal Exchange; Pregnanc | 1986 |
[Preclinical and clinical studies on aztreonam in obstetrics and gynecology].
Topics: Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Female; Genital | 1985 |
[Clinical effect of aztreonam in infections in obstetrics and gynecology].
Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Gen | 1985 |
[Clinical efficacy of aztreonam in pelvic peritonitis].
Topics: Adult; Aztreonam; Drug Evaluation; Female; Humans; Middle Aged; Pelvis; Peritonitis; Pregnancy; Puer | 1985 |
[Clinical evaluation of aztreonam in the field of obstetrics and gynecology].
Topics: Adolescent; Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance | 1985 |
[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology].
Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Genitalia | 1985 |
[Clinical trial of aztreonam in the field of obstetrics and gynecology].
Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Hum | 1985 |
[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology].
Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Exudates and Transudates; Female; Genital D | 1985 |
[In vitro activity and clinical evaluation of aztreonam in the field of obstetrics and gynecology].
Topics: Adult; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Femal | 1985 |
[Fundamental and clinical studies of aztreonam in the field of obstetrics and gynecology].
Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Gen | 1985 |
[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology].
Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Gen | 1985 |
[Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology].
Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Genitalia | 1985 |
[Fundamental and clinical studies on aztreonam].
Topics: Adolescent; Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Exudates and Transudates; | 1985 |
[Clinical experience with aztreonam in the field of obstetrics and gynecology].
Topics: Adolescent; Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Femal | 1985 |
[Clinical evaluation of aztreonam in the field of obstetrics and gynecology].
Topics: Adult; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Genital Diseases, Female; Humans; M | 1985 |
[Fundamental and clinical studies on aztreonam in obstetrics and gynecology].
Topics: Adult; Aged; Amniotic Fluid; Aztreonam; Bacterial Infections; Exudates and Transudates; Female; Feta | 1985 |
[Clinical review and antibacterial effect of aztreonam in infections in obstetrics and gynecology].
Topics: Adult; Aztreonam; Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Femal | 1985 |